| 1 |
Hung K, Kowalczyk R, Desai A, Brimble MA, Marshall JF, Harris PWR. Synthesis and Systematic Study on the Effect of Different PEG Units on Stability of PEGylated, Integrin-αvβ6-Specific A20FMDV2 Analogues in Rat Serum and Human Plasma. Molecules 2022;27:4331. [DOI: 10.3390/molecules27144331] [Reference Citation Analysis]
|
| 2 |
Lu Q, Long Y, Fan K, Shen Z, Gai Y, Liu Q, Jiang D, Cai W, Wan C, Lan X. PET imaging of hepatocellular carcinoma by targeting tumor-associated endothelium using [68Ga]Ga-PSMA-617. Eur J Nucl Med Mol Imaging 2022. [PMID: 35763056 DOI: 10.1007/s00259-022-05884-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 3 |
Huynh TT, Sreekumar S, Mpoy C, Rogers BE. Therapeutic Efficacy of 177Lu-Labeled A20FMDV2 Peptides Targeting ανβ6. Pharmaceuticals 2022;15:229. [DOI: 10.3390/ph15020229] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 4 |
Ganguly T, Bauer N, Davis RA, Hausner SH, Tang SY, Sutcliffe JL. Evaluation of Copper-64-Labeled α(v)β(6)-Targeting Peptides: Addition of an Albumin Binding Moiety to Improve Pharmacokinetics. Mol Pharm 2021;18:4437-47. [PMID: 34783573 DOI: 10.1021/acs.molpharmaceut.1c00632] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Ganguly T, Tang SY, Bauer N, Sutcliffe JL. Evaluation of Two Optical Probes for Imaging the Integrin αvβ6- In Vitro and In Vivo in Tumor-Bearing Mice. Mol Imaging Biol 2020;22:1170-81. [PMID: 32002763 DOI: 10.1007/s11307-019-01469-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 6 |
Urquiza M, Guevara V, Diaz-sana E, Mora F. The Role of αvβ6 Integrin Binding Molecules in the Diagnosis and Treatment of Cancer. COC 2020;24:2393-411. [DOI: 10.2174/1385272824999200528124936] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 7 |
Nakamura S, Matsuno A, Ueda M. Improvement of biodistribution profile of a radiogallium-labeled, αvβ6 integrin-targeting peptide probe by incorporation of negatively charged amino acids. Ann Nucl Med 2020;34:575-82. [DOI: 10.1007/s12149-020-01483-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 8 |
Onega M, Parker CA, Coello C, Rizzo G, Keat N, Ramada-Magalhaes J, Moz S, Tang SP, Plisson C, Wells L, Ashworth S, Slack RJ, Vitulli G, Wilson FJ, Gunn R, Lukey PT, Passchier J. Preclinical evaluation of [18F]FB-A20FMDV2 as a selective marker for measuring αVβ6 integrin occupancy using positron emission tomography in rodent lung. Eur J Nucl Med Mol Imaging 2020;47:958-66. [PMID: 31897589 DOI: 10.1007/s00259-019-04653-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 9 |
Ui T, Ueda M, Higaki Y, Kamino S, Sano K, Kimura H, Saji H, Enomoto S. Development and characterization of a 68Ga-labeled A20FMDV2 peptide probe for the PET imaging of αvβ6 integrin-positive pancreatic ductal adenocarcinoma. Bioorg Med Chem 2020;28:115189. [PMID: 31740201 DOI: 10.1016/j.bmc.2019.115189] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 10 |
Davis RA, Hausner SH, Sutcliffe JL. Peptides as Radiopharmaceutical Vectors. In: Lewis JS, Windhorst AD, Zeglis BM, editors. Radiopharmaceutical Chemistry. Cham: Springer International Publishing; 2019. pp. 137-62. [DOI: 10.1007/978-3-319-98947-1_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 11 |
Flechsig P, Lindner T, Loktev A, Roesch S, Mier W, Sauter M, Meister M, Herold-mende C, Haberkorn U, Altmann A. PET/CT Imaging of NSCLC with a αvβ6 Integrin-Targeting Peptide. Mol Imaging Biol 2019;21:973-83. [DOI: 10.1007/s11307-018-1296-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 12 |
Ling X, Cutler CS, Anderson CJ. The Radiopharmaceutical Chemistry of the Radioisotopes of Copper. Radiopharmaceutical Chemistry 2019. [DOI: 10.1007/978-3-319-98947-1_19] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 13 |
Liu H, Gao L, Yu X, Zhong L, Shi J, Jia B, Li N, Liu Z, Wang F. Small-animal SPECT/CT imaging of cancer xenografts and pulmonary fibrosis using a 99mTc-labeled integrin αvβ6-targeting cyclic peptide with improved in vivo stability. Biophys Rep 2018;4:254-64. [PMID: 30533490 DOI: 10.1007/s41048-018-0071-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 14 |
Bengel FM, Ross TL. Emerging imaging targets for infiltrative cardiomyopathy: Inflammation and fibrosis. J Nucl Cardiol 2019;26:208-16. [PMID: 29968156 DOI: 10.1007/s12350-018-1356-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 15 |
Tolmachev V, Grönroos TJ, Yim CB, Garousi J, Yue Y, Grimm S, Rajander J, Perols A, Haaparanta-Solin M, Solin O, Ferdani R, Orlova A, Anderson CJ, Karlström AE. Molecular design of radiocopper-labelled Affibody molecules. Sci Rep 2018;8:6542. [PMID: 29695813 DOI: 10.1038/s41598-018-24785-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 16 |
Rylova SN, Stoykow C, Del Pozzo L, Abiraj K, Tamma ML, Kiefer Y, Fani M, Maecke HR. The somatostatin receptor 2 antagonist 64Cu-NODAGA-JR11 outperforms 64Cu-DOTA-TATE in a mouse xenograft model. PLoS One 2018;13:e0195802. [PMID: 29668724 DOI: 10.1371/journal.pone.0195802] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 17 |
Niu J, Li Z. The roles of integrin αvβ6 in cancer. Cancer Letters 2017;403:128-37. [DOI: 10.1016/j.canlet.2017.06.012] [Cited by in Crossref: 73] [Cited by in F6Publishing: 82] [Article Influence: 12.2] [Reference Citation Analysis]
|
| 18 |
Hung KY, Harris PWR, Desai A, Marshall JF, Brimble MA. Structure-activity relationship study of the tumour-targeting peptide A20FMDV2 via modification of Lys16, Leu13, and N- and/or C-terminal functionality. Eur J Med Chem 2017;136:154-64. [PMID: 28494253 DOI: 10.1016/j.ejmech.2017.05.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 19 |
Tolmachev V, Yim CB, Rajander J, Perols A, Karlström AE, Haaparanta-Solin M, Grönroos TJ, Solin O, Orlova A. Comparative Evaluation of Anti-HER2 Affibody Molecules Labeled with 64Cu Using NOTA and NODAGA. Contrast Media Mol Imaging 2017;2017:8565802. [PMID: 29097939 DOI: 10.1155/2017/8565802] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 20 |
Abadjian MZ, Edwards WB, Anderson CJ. Imaging the Tumor Microenvironment. Adv Exp Med Biol 2017;1036:229-57. [PMID: 29275475 DOI: 10.1007/978-3-319-67577-0_15] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 21 |
Paterson BM, Donnelly PS. Macrocyclic Bifunctional Chelators and Conjugation Strategies for Copper-64 Radiopharmaceuticals. Insights from Imaging in Bioinorganic Chemistry. Elsevier; 2016. pp. 223-51. [DOI: 10.1016/bs.adioch.2015.09.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 22 |
Roosenburg S, Laverman P, Joosten L, Cooper MS, Kolenc-Peitl PK, Foster JM, Hudson C, Leyton J, Burnet J, Oyen WJ, Blower PJ, Mather SJ, Boerman OC, Sosabowski JK. PET and SPECT imaging of a radiolabeled minigastrin analogue conjugated with DOTA, NOTA, and NODAGA and labeled with (64)Cu, (68)Ga, and (111)In. Mol Pharm 2014;11:3930-7. [PMID: 24992368 DOI: 10.1021/mp500283k] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 23 |
Haubner R, Maschauer S, Prante O. PET radiopharmaceuticals for imaging integrin expression: tracers in clinical studies and recent developments. Biomed Res Int 2014;2014:871609. [PMID: 25013808 DOI: 10.1155/2014/871609] [Cited by in Crossref: 36] [Cited by in F6Publishing: 48] [Article Influence: 4.0] [Reference Citation Analysis]
|
